Patent · US Active

Composition for treating hearing loss

US8927528B2 · kind B2 · utility

1Cited by

16References

20Claims

0Family size

Assignee

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · US

Inventors

Josef Miller · Ann Arbor, US
Colleen LePrell · Gainesville, US
Jochen Schact · Ann Arbor, US
Diane Prieskorn · Livonia, US

Key dates

Filing date	Nov 16, 2012
Grant date	Jan 6, 2015
Priority date	—
Expiry date	Jul 3, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composition to be administered to a mammal for treating hearing loss is disclosed herein. The composition consists essentially of a biologically effective amount of vitamin A, vitamin C, vitamin E, and a vasodilator comprising magnesium. The composition optionally includes a withanolide and/or resveratrol. The vitamin A, vitamin C, vitamin E, and the vasodilator comprising magnesium provides an additive effect that is equal to or greater than a sum of the effects of the individual components.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.